More tools:Markets·Screener·Research·Chat

Enveric Biosciences, Inc. Common Stock (ENVB) Financial Statements

Enveric Biosciences, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S5W660
XNAS · usd
1.42▲ 0.03 (2.16%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close1.39
Day's Range1.38 – 1.45
52-Week Range0.56 – 13.25
Volume42.5K
Avg Volume117.5K
Share Statistics
Shares Outstanding
Employees6
ExchangeXNAS
Listed1995-08-24
Share count as of August 12, 2026
Loading Income Statement…
Key questions about Enveric Biosciences, Inc. Common Stock (ENVB)
What is Enveric Biosciences, Inc. Common Stock's Market Cap?
Enveric Biosciences, Inc. Common Stock's Market Cap is $6.4M, based on as-reported figures from SEC (XBRL) filings.
What is Enveric Biosciences, Inc. Common Stock's Enterprise Value?
Enveric Biosciences, Inc. Common Stock's Enterprise Value is -$1.9M, based on as-reported figures from SEC (XBRL) filings.
What is Enveric Biosciences, Inc. Common Stock's EV / EBITDA?
Enveric Biosciences, Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Enveric Biosciences, Inc. Common Stock's Net Income (TTM)?
Enveric Biosciences, Inc. Common Stock's Net Income (TTM) is -$12.1M, based on as-reported figures from SEC (XBRL) filings.
What is Enveric Biosciences, Inc. Common Stock's EBITDA?
Enveric Biosciences, Inc. Common Stock's EBITDA is -$8.6M, based on as-reported figures from SEC (XBRL) filings.
What is Enveric Biosciences, Inc. Common Stock's Diluted EPS (TTM)?
Enveric Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -2.70, based on as-reported figures from SEC (XBRL) filings.
What is Enveric Biosciences, Inc. Common Stock's Net Debt?
Enveric Biosciences, Inc. Common Stock's Net Debt is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses
Selling, General and Administrative Expense—
Research and Development Expense—
Depreciation Expense—
Total operating expenses—
Loss from operations—
Other (expense) income
Other Income————
Net Interest Income—
Total other (expense) income—
Net loss before income taxes—
Net loss
Earnings Per Share (Basic)——
Earnings Per Share (Diluted)——